nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—CYP2D6—Niacin—atherosclerosis	0.0777	0.108	CbGbCtD
Reboxetine—ABCB1—Ezetimibe—atherosclerosis	0.0701	0.0972	CbGbCtD
Reboxetine—ABCB1—Simvastatin—atherosclerosis	0.0652	0.0903	CbGbCtD
Reboxetine—ABCB1—Lovastatin—atherosclerosis	0.0638	0.0884	CbGbCtD
Reboxetine—ABCB1—Pravastatin—atherosclerosis	0.0638	0.0884	CbGbCtD
Reboxetine—CYP2D6—Simvastatin—atherosclerosis	0.0614	0.0851	CbGbCtD
Reboxetine—CYP2D6—Pravastatin—atherosclerosis	0.0601	0.0833	CbGbCtD
Reboxetine—CYP2D6—Lovastatin—atherosclerosis	0.0601	0.0833	CbGbCtD
Reboxetine—CYP3A4—Rosuvastatin—atherosclerosis	0.042	0.0582	CbGbCtD
Reboxetine—CYP3A4—Ezetimibe—atherosclerosis	0.042	0.0582	CbGbCtD
Reboxetine—CYP3A4—Simvastatin—atherosclerosis	0.039	0.0541	CbGbCtD
Reboxetine—CYP3A4—Lovastatin—atherosclerosis	0.0382	0.053	CbGbCtD
Reboxetine—CYP3A4—Pravastatin—atherosclerosis	0.0382	0.053	CbGbCtD
Reboxetine—Diphenylpyraline—HRH1—atherosclerosis	0.00221	0.284	CrCbGaD
Reboxetine—Cyclizine—HRH1—atherosclerosis	0.00178	0.229	CrCbGaD
Reboxetine—Benzatropine—HRH1—atherosclerosis	0.00169	0.218	CrCbGaD
Reboxetine—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00123	0.00542	CcSEcCtD
Reboxetine—Influenza—Ezetimibe—atherosclerosis	0.00122	0.00539	CcSEcCtD
Reboxetine—Diplopia—Pravastatin—atherosclerosis	0.00122	0.00537	CcSEcCtD
Reboxetine—Face oedema—Niacin—atherosclerosis	0.00119	0.00527	CcSEcCtD
Reboxetine—Muscular weakness—Simvastatin—atherosclerosis	0.00119	0.00524	CcSEcCtD
Reboxetine—Rhinitis—Rosuvastatin—atherosclerosis	0.00118	0.0052	CcSEcCtD
Reboxetine—Urinary retention—Niacin—atherosclerosis	0.00118	0.00519	CcSEcCtD
Reboxetine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00117	0.00515	CcSEcCtD
Reboxetine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00115	0.00506	CcSEcCtD
Reboxetine—Liver function test abnormal—Niacin—atherosclerosis	0.00114	0.00504	CcSEcCtD
Reboxetine—Orthostatic hypotension—Niacin—atherosclerosis	0.00113	0.00499	CcSEcCtD
Reboxetine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00112	0.00496	CcSEcCtD
Reboxetine—Liver function test abnormal—Pravastatin—atherosclerosis	0.00112	0.00496	CcSEcCtD
Reboxetine—Bronchitis—Simvastatin—atherosclerosis	0.00112	0.00494	CcSEcCtD
Reboxetine—Muscular weakness—Niacin—atherosclerosis	0.00109	0.00481	CcSEcCtD
Reboxetine—Infestation—Ezetimibe—atherosclerosis	0.00109	0.0048	CcSEcCtD
Reboxetine—Infestation NOS—Ezetimibe—atherosclerosis	0.00109	0.0048	CcSEcCtD
Reboxetine—Urinary tract infection—Lovastatin—atherosclerosis	0.00108	0.00476	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00107	0.00474	CcSEcCtD
Reboxetine—Muscular weakness—Pravastatin—atherosclerosis	0.00107	0.00474	CcSEcCtD
Reboxetine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00107	0.00473	CcSEcCtD
Reboxetine—Influenza—Niacin—atherosclerosis	0.00107	0.00472	CcSEcCtD
Reboxetine—Influenza—Pravastatin—atherosclerosis	0.00105	0.00465	CcSEcCtD
Reboxetine—Sinusitis—Lovastatin—atherosclerosis	0.00104	0.0046	CcSEcCtD
Reboxetine—Mental disorder—Rosuvastatin—atherosclerosis	0.00103	0.00455	CcSEcCtD
Reboxetine—Bronchitis—Niacin—atherosclerosis	0.00103	0.00454	CcSEcCtD
Reboxetine—Sinusitis—Ezetimibe—atherosclerosis	0.00102	0.00451	CcSEcCtD
Reboxetine—Erectile dysfunction—Niacin—atherosclerosis	0.000984	0.00435	CcSEcCtD
Reboxetine—Dysuria—Pravastatin—atherosclerosis	0.000984	0.00434	CcSEcCtD
Reboxetine—Sinusitis—Simvastatin—atherosclerosis	0.000974	0.0043	CcSEcCtD
Reboxetine—Pharyngitis—Ezetimibe—atherosclerosis	0.000969	0.00428	CcSEcCtD
Reboxetine—Erectile dysfunction—Pravastatin—atherosclerosis	0.000969	0.00428	CcSEcCtD
Reboxetine—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00096	0.00424	CcSEcCtD
Reboxetine—Weight decreased—Pravastatin—atherosclerosis	0.000952	0.0042	CcSEcCtD
Reboxetine—Sweating—Niacin—atherosclerosis	0.000913	0.00403	CcSEcCtD
Reboxetine—Urinary tract infection—Pravastatin—atherosclerosis	0.000912	0.00403	CcSEcCtD
Reboxetine—Chills—Lovastatin—atherosclerosis	0.000894	0.00395	CcSEcCtD
Reboxetine—Angiopathy—Ezetimibe—atherosclerosis	0.000886	0.00391	CcSEcCtD
Reboxetine—Immune system disorder—Ezetimibe—atherosclerosis	0.000882	0.0039	CcSEcCtD
Reboxetine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00088	0.00389	CcSEcCtD
Reboxetine—Sinusitis—Pravastatin—atherosclerosis	0.00088	0.00389	CcSEcCtD
Reboxetine—Diphenhydramine—HRH1—atherosclerosis	0.000871	0.112	CrCbGaD
Reboxetine—Rhinitis—Niacin—atherosclerosis	0.000858	0.00379	CcSEcCtD
Reboxetine—Mental disorder—Ezetimibe—atherosclerosis	0.000856	0.00378	CcSEcCtD
Reboxetine—Malnutrition—Ezetimibe—atherosclerosis	0.00085	0.00375	CcSEcCtD
Reboxetine—Dysgeusia—Lovastatin—atherosclerosis	0.000849	0.00375	CcSEcCtD
Reboxetine—Rhinitis—Pravastatin—atherosclerosis	0.000844	0.00373	CcSEcCtD
Reboxetine—Confusional state—Rosuvastatin—atherosclerosis	0.000842	0.00372	CcSEcCtD
Reboxetine—Pharyngitis—Pravastatin—atherosclerosis	0.000836	0.00369	CcSEcCtD
Reboxetine—Chills—Simvastatin—atherosclerosis	0.000836	0.00369	CcSEcCtD
Reboxetine—Infection—Rosuvastatin—atherosclerosis	0.000829	0.00366	CcSEcCtD
Reboxetine—Visual impairment—Niacin—atherosclerosis	0.000824	0.00364	CcSEcCtD
Reboxetine—Orphenadrine—HRH1—atherosclerosis	0.000823	0.106	CrCbGaD
Reboxetine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000819	0.00362	CcSEcCtD
Reboxetine—Mental disorder—Simvastatin—atherosclerosis	0.000816	0.0036	CcSEcCtD
Reboxetine—Tremor—Lovastatin—atherosclerosis	0.000812	0.00359	CcSEcCtD
Reboxetine—Visual impairment—Pravastatin—atherosclerosis	0.000812	0.00358	CcSEcCtD
Reboxetine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000804	0.00355	CcSEcCtD
Reboxetine—Eye disorder—Niacin—atherosclerosis	0.000799	0.00353	CcSEcCtD
Reboxetine—Tinnitus—Niacin—atherosclerosis	0.000798	0.00352	CcSEcCtD
Reboxetine—Dysgeusia—Simvastatin—atherosclerosis	0.000794	0.00351	CcSEcCtD
Reboxetine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000789	0.00348	CcSEcCtD
Reboxetine—Anaemia—Ezetimibe—atherosclerosis	0.000786	0.00347	CcSEcCtD
Reboxetine—Tinnitus—Pravastatin—atherosclerosis	0.000785	0.00347	CcSEcCtD
Reboxetine—Malaise—Lovastatin—atherosclerosis	0.000782	0.00345	CcSEcCtD
Reboxetine—Cardiac disorder—Pravastatin—atherosclerosis	0.000782	0.00345	CcSEcCtD
Reboxetine—Vertigo—Lovastatin—atherosclerosis	0.000779	0.00344	CcSEcCtD
Reboxetine—Angiopathy—Niacin—atherosclerosis	0.000776	0.00343	CcSEcCtD
Reboxetine—Leukopenia—Lovastatin—atherosclerosis	0.000776	0.00343	CcSEcCtD
Reboxetine—Chills—Niacin—atherosclerosis	0.000767	0.00339	CcSEcCtD
Reboxetine—Malaise—Ezetimibe—atherosclerosis	0.000767	0.00339	CcSEcCtD
Reboxetine—Tremor—Simvastatin—atherosclerosis	0.00076	0.00335	CcSEcCtD
Reboxetine—Chills—Pravastatin—atherosclerosis	0.000756	0.00334	CcSEcCtD
Reboxetine—Insomnia—Rosuvastatin—atherosclerosis	0.000755	0.00333	CcSEcCtD
Reboxetine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000752	0.00332	CcSEcCtD
Reboxetine—Palpitations—Ezetimibe—atherosclerosis	0.000751	0.00332	CcSEcCtD
Reboxetine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00075	0.00331	CcSEcCtD
Reboxetine—Anaemia—Simvastatin—atherosclerosis	0.00075	0.00331	CcSEcCtD
Reboxetine—Malnutrition—Niacin—atherosclerosis	0.000745	0.00329	CcSEcCtD
Reboxetine—Chest pain—Lovastatin—atherosclerosis	0.000738	0.00326	CcSEcCtD
Reboxetine—Anxiety—Lovastatin—atherosclerosis	0.000736	0.00325	CcSEcCtD
Reboxetine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000735	0.00324	CcSEcCtD
Reboxetine—Hypertension—Ezetimibe—atherosclerosis	0.000734	0.00324	CcSEcCtD
Reboxetine—Malaise—Simvastatin—atherosclerosis	0.000731	0.00323	CcSEcCtD
Reboxetine—Tension—Niacin—atherosclerosis	0.000731	0.00323	CcSEcCtD
Reboxetine—Discomfort—Lovastatin—atherosclerosis	0.000729	0.00322	CcSEcCtD
Reboxetine—Vertigo—Simvastatin—atherosclerosis	0.000729	0.00322	CcSEcCtD
Reboxetine—Leukopenia—Simvastatin—atherosclerosis	0.000726	0.0032	CcSEcCtD
Reboxetine—Chest pain—Ezetimibe—atherosclerosis	0.000724	0.0032	CcSEcCtD
Reboxetine—Nervousness—Niacin—atherosclerosis	0.000723	0.00319	CcSEcCtD
Reboxetine—Dry mouth—Lovastatin—atherosclerosis	0.000722	0.00319	CcSEcCtD
Reboxetine—Tension—Pravastatin—atherosclerosis	0.000719	0.00318	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000719	0.00317	CcSEcCtD
Reboxetine—Dysgeusia—Pravastatin—atherosclerosis	0.000718	0.00317	CcSEcCtD
Reboxetine—Discomfort—Ezetimibe—atherosclerosis	0.000715	0.00316	CcSEcCtD
Reboxetine—Constipation—Rosuvastatin—atherosclerosis	0.000714	0.00315	CcSEcCtD
Reboxetine—Confusional state—Lovastatin—atherosclerosis	0.000713	0.00315	CcSEcCtD
Reboxetine—Nervousness—Pravastatin—atherosclerosis	0.000712	0.00314	CcSEcCtD
Reboxetine—Dry mouth—Ezetimibe—atherosclerosis	0.000708	0.00313	CcSEcCtD
Reboxetine—Infection—Lovastatin—atherosclerosis	0.000703	0.0031	CcSEcCtD
Reboxetine—Confusional state—Ezetimibe—atherosclerosis	0.0007	0.00309	CcSEcCtD
Reboxetine—Chest pain—Simvastatin—atherosclerosis	0.00069	0.00305	CcSEcCtD
Reboxetine—Infection—Ezetimibe—atherosclerosis	0.000689	0.00304	CcSEcCtD
Reboxetine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000688	0.00304	CcSEcCtD
Reboxetine—Anxiety—Simvastatin—atherosclerosis	0.000688	0.00304	CcSEcCtD
Reboxetine—Tremor—Pravastatin—atherosclerosis	0.000687	0.00303	CcSEcCtD
Reboxetine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000683	0.00301	CcSEcCtD
Reboxetine—Discomfort—Simvastatin—atherosclerosis	0.000682	0.00301	CcSEcCtD
Reboxetine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000681	0.003	CcSEcCtD
Reboxetine—Ill-defined disorder—Pravastatin—atherosclerosis	0.00068	0.003	CcSEcCtD
Reboxetine—Anaemia—Pravastatin—atherosclerosis	0.000678	0.00299	CcSEcCtD
Reboxetine—Anorexia—Lovastatin—atherosclerosis	0.000674	0.00298	CcSEcCtD
Reboxetine—Skin disorder—Ezetimibe—atherosclerosis	0.000674	0.00298	CcSEcCtD
Reboxetine—Vertigo—Niacin—atherosclerosis	0.000669	0.00295	CcSEcCtD
Reboxetine—Syncope—Niacin—atherosclerosis	0.000668	0.00295	CcSEcCtD
Reboxetine—Confusional state—Simvastatin—atherosclerosis	0.000667	0.00295	CcSEcCtD
Reboxetine—Leukopenia—Niacin—atherosclerosis	0.000667	0.00294	CcSEcCtD
Reboxetine—Urticaria—Rosuvastatin—atherosclerosis	0.000663	0.00293	CcSEcCtD
Reboxetine—Malaise—Pravastatin—atherosclerosis	0.000661	0.00292	CcSEcCtD
Reboxetine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00066	0.00291	CcSEcCtD
Reboxetine—Vertigo—Pravastatin—atherosclerosis	0.000659	0.00291	CcSEcCtD
Reboxetine—Palpitations—Niacin—atherosclerosis	0.000658	0.00291	CcSEcCtD
Reboxetine—Infection—Simvastatin—atherosclerosis	0.000658	0.0029	CcSEcCtD
Reboxetine—Leukopenia—Pravastatin—atherosclerosis	0.000656	0.0029	CcSEcCtD
Reboxetine—Loss of consciousness—Niacin—atherosclerosis	0.000654	0.00289	CcSEcCtD
Reboxetine—Insomnia—Lovastatin—atherosclerosis	0.00064	0.00283	CcSEcCtD
Reboxetine—Paraesthesia—Lovastatin—atherosclerosis	0.000635	0.00281	CcSEcCtD
Reboxetine—Hypertension—Pravastatin—atherosclerosis	0.000633	0.00279	CcSEcCtD
Reboxetine—Anorexia—Simvastatin—atherosclerosis	0.000631	0.00279	CcSEcCtD
Reboxetine—Dyspnoea—Lovastatin—atherosclerosis	0.000631	0.00279	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00063	0.00278	CcSEcCtD
Reboxetine—Insomnia—Ezetimibe—atherosclerosis	0.000628	0.00277	CcSEcCtD
Reboxetine—Chest pain—Pravastatin—atherosclerosis	0.000624	0.00276	CcSEcCtD
Reboxetine—Paraesthesia—Ezetimibe—atherosclerosis	0.000623	0.00275	CcSEcCtD
Reboxetine—Dyspepsia—Lovastatin—atherosclerosis	0.000623	0.00275	CcSEcCtD
Reboxetine—Anxiety—Pravastatin—atherosclerosis	0.000622	0.00275	CcSEcCtD
Reboxetine—Dry mouth—Niacin—atherosclerosis	0.00062	0.00274	CcSEcCtD
Reboxetine—Dyspnoea—Ezetimibe—atherosclerosis	0.000619	0.00273	CcSEcCtD
Reboxetine—Discomfort—Pravastatin—atherosclerosis	0.000617	0.00272	CcSEcCtD
Reboxetine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000615	0.00272	CcSEcCtD
Reboxetine—Decreased appetite—Lovastatin—atherosclerosis	0.000615	0.00272	CcSEcCtD
Reboxetine—Dyspepsia—Ezetimibe—atherosclerosis	0.000611	0.0027	CcSEcCtD
Reboxetine—Constipation—Lovastatin—atherosclerosis	0.000605	0.00267	CcSEcCtD
Reboxetine—Confusional state—Pravastatin—atherosclerosis	0.000603	0.00266	CcSEcCtD
Reboxetine—Decreased appetite—Ezetimibe—atherosclerosis	0.000603	0.00266	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000599	0.00265	CcSEcCtD
Reboxetine—Asthenia—Rosuvastatin—atherosclerosis	0.000599	0.00264	CcSEcCtD
Reboxetine—Insomnia—Simvastatin—atherosclerosis	0.000599	0.00264	CcSEcCtD
Reboxetine—Shock—Niacin—atherosclerosis	0.000598	0.00264	CcSEcCtD
Reboxetine—Infection—Pravastatin—atherosclerosis	0.000594	0.00262	CcSEcCtD
Reboxetine—Paraesthesia—Simvastatin—atherosclerosis	0.000594	0.00262	CcSEcCtD
Reboxetine—Constipation—Ezetimibe—atherosclerosis	0.000593	0.00262	CcSEcCtD
Reboxetine—Tachycardia—Niacin—atherosclerosis	0.000593	0.00262	CcSEcCtD
Reboxetine—Skin disorder—Niacin—atherosclerosis	0.00059	0.00261	CcSEcCtD
Reboxetine—Dyspnoea—Simvastatin—atherosclerosis	0.00059	0.00261	CcSEcCtD
Reboxetine—Hyperhidrosis—Niacin—atherosclerosis	0.000587	0.00259	CcSEcCtD
Reboxetine—Feeling abnormal—Lovastatin—atherosclerosis	0.000583	0.00257	CcSEcCtD
Reboxetine—Dyspepsia—Simvastatin—atherosclerosis	0.000583	0.00257	CcSEcCtD
Reboxetine—Anorexia—Niacin—atherosclerosis	0.000579	0.00256	CcSEcCtD
Reboxetine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000579	0.00255	CcSEcCtD
Reboxetine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000578	0.00255	CcSEcCtD
Reboxetine—Decreased appetite—Simvastatin—atherosclerosis	0.000575	0.00254	CcSEcCtD
Reboxetine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000572	0.00252	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000571	0.00252	CcSEcCtD
Reboxetine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000571	0.00252	CcSEcCtD
Reboxetine—Anorexia—Pravastatin—atherosclerosis	0.00057	0.00252	CcSEcCtD
Reboxetine—Hypotension—Niacin—atherosclerosis	0.000568	0.00251	CcSEcCtD
Reboxetine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000567	0.00251	CcSEcCtD
Reboxetine—Constipation—Simvastatin—atherosclerosis	0.000566	0.0025	CcSEcCtD
Reboxetine—Urticaria—Lovastatin—atherosclerosis	0.000562	0.00248	CcSEcCtD
Reboxetine—Body temperature increased—Lovastatin—atherosclerosis	0.000559	0.00247	CcSEcCtD
Reboxetine—Abdominal pain—Lovastatin—atherosclerosis	0.000559	0.00247	CcSEcCtD
Reboxetine—Dizziness—Rosuvastatin—atherosclerosis	0.000552	0.00244	CcSEcCtD
Reboxetine—Urticaria—Ezetimibe—atherosclerosis	0.000551	0.00243	CcSEcCtD
Reboxetine—Insomnia—Niacin—atherosclerosis	0.00055	0.00243	CcSEcCtD
Reboxetine—Body temperature increased—Ezetimibe—atherosclerosis	0.000549	0.00242	CcSEcCtD
Reboxetine—Abdominal pain—Ezetimibe—atherosclerosis	0.000549	0.00242	CcSEcCtD
Reboxetine—Paraesthesia—Niacin—atherosclerosis	0.000546	0.00241	CcSEcCtD
Reboxetine—Feeling abnormal—Simvastatin—atherosclerosis	0.000545	0.00241	CcSEcCtD
Reboxetine—Dyspnoea—Niacin—atherosclerosis	0.000542	0.00239	CcSEcCtD
Reboxetine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000541	0.00239	CcSEcCtD
Reboxetine—Insomnia—Pravastatin—atherosclerosis	0.000541	0.00239	CcSEcCtD
Reboxetine—Somnolence—Niacin—atherosclerosis	0.00054	0.00239	CcSEcCtD
Reboxetine—Paraesthesia—Pravastatin—atherosclerosis	0.000537	0.00237	CcSEcCtD
Reboxetine—Dyspepsia—Niacin—atherosclerosis	0.000535	0.00236	CcSEcCtD
Reboxetine—Dyspnoea—Pravastatin—atherosclerosis	0.000533	0.00236	CcSEcCtD
Reboxetine—Decreased appetite—Niacin—atherosclerosis	0.000528	0.00233	CcSEcCtD
Reboxetine—Dyspepsia—Pravastatin—atherosclerosis	0.000527	0.00233	CcSEcCtD
Reboxetine—Rash—Rosuvastatin—atherosclerosis	0.000526	0.00232	CcSEcCtD
Reboxetine—Dermatitis—Rosuvastatin—atherosclerosis	0.000526	0.00232	CcSEcCtD
Reboxetine—Urticaria—Simvastatin—atherosclerosis	0.000526	0.00232	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000525	0.00232	CcSEcCtD
Reboxetine—Body temperature increased—Simvastatin—atherosclerosis	0.000523	0.00231	CcSEcCtD
Reboxetine—Abdominal pain—Simvastatin—atherosclerosis	0.000523	0.00231	CcSEcCtD
Reboxetine—Headache—Rosuvastatin—atherosclerosis	0.000523	0.00231	CcSEcCtD
Reboxetine—Hypersensitivity—Lovastatin—atherosclerosis	0.000521	0.0023	CcSEcCtD
Reboxetine—Decreased appetite—Pravastatin—atherosclerosis	0.00052	0.0023	CcSEcCtD
Reboxetine—Constipation—Pravastatin—atherosclerosis	0.000512	0.00226	CcSEcCtD
Reboxetine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000511	0.00226	CcSEcCtD
Reboxetine—Asthenia—Lovastatin—atherosclerosis	0.000508	0.00224	CcSEcCtD
Reboxetine—Asthenia—Ezetimibe—atherosclerosis	0.000498	0.0022	CcSEcCtD
Reboxetine—Gastrointestinal pain—Niacin—atherosclerosis	0.000497	0.00219	CcSEcCtD
Reboxetine—Nausea—Rosuvastatin—atherosclerosis	0.000496	0.00219	CcSEcCtD
Reboxetine—Feeling abnormal—Pravastatin—atherosclerosis	0.000493	0.00218	CcSEcCtD
Reboxetine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000489	0.00216	CcSEcCtD
Reboxetine—Hypersensitivity—Simvastatin—atherosclerosis	0.000488	0.00215	CcSEcCtD
Reboxetine—Diarrhoea—Lovastatin—atherosclerosis	0.000484	0.00214	CcSEcCtD
Reboxetine—Urticaria—Niacin—atherosclerosis	0.000483	0.00213	CcSEcCtD
Reboxetine—Body temperature increased—Niacin—atherosclerosis	0.00048	0.00212	CcSEcCtD
Reboxetine—Abdominal pain—Niacin—atherosclerosis	0.00048	0.00212	CcSEcCtD
Reboxetine—Urticaria—Pravastatin—atherosclerosis	0.000475	0.0021	CcSEcCtD
Reboxetine—Asthenia—Simvastatin—atherosclerosis	0.000475	0.0021	CcSEcCtD
Reboxetine—Diarrhoea—Ezetimibe—atherosclerosis	0.000475	0.0021	CcSEcCtD
Reboxetine—Abdominal pain—Pravastatin—atherosclerosis	0.000473	0.00209	CcSEcCtD
Reboxetine—Body temperature increased—Pravastatin—atherosclerosis	0.000473	0.00209	CcSEcCtD
Reboxetine—Dizziness—Lovastatin—atherosclerosis	0.000468	0.00207	CcSEcCtD
Reboxetine—Dizziness—Ezetimibe—atherosclerosis	0.000459	0.00203	CcSEcCtD
Reboxetine—Diarrhoea—Simvastatin—atherosclerosis	0.000453	0.002	CcSEcCtD
Reboxetine—Vomiting—Lovastatin—atherosclerosis	0.00045	0.00199	CcSEcCtD
Reboxetine—Hypersensitivity—Niacin—atherosclerosis	0.000448	0.00198	CcSEcCtD
Reboxetine—Rash—Lovastatin—atherosclerosis	0.000446	0.00197	CcSEcCtD
Reboxetine—Dermatitis—Lovastatin—atherosclerosis	0.000446	0.00197	CcSEcCtD
Reboxetine—Headache—Lovastatin—atherosclerosis	0.000443	0.00196	CcSEcCtD
Reboxetine—Vomiting—Ezetimibe—atherosclerosis	0.000441	0.00195	CcSEcCtD
Reboxetine—Hypersensitivity—Pravastatin—atherosclerosis	0.000441	0.00195	CcSEcCtD
Reboxetine—Dizziness—Simvastatin—atherosclerosis	0.000438	0.00193	CcSEcCtD
Reboxetine—Rash—Ezetimibe—atherosclerosis	0.000438	0.00193	CcSEcCtD
Reboxetine—Dermatitis—Ezetimibe—atherosclerosis	0.000437	0.00193	CcSEcCtD
Reboxetine—Asthenia—Niacin—atherosclerosis	0.000436	0.00193	CcSEcCtD
Reboxetine—Headache—Ezetimibe—atherosclerosis	0.000435	0.00192	CcSEcCtD
Reboxetine—Asthenia—Pravastatin—atherosclerosis	0.000429	0.0019	CcSEcCtD
Reboxetine—Vomiting—Simvastatin—atherosclerosis	0.000421	0.00186	CcSEcCtD
Reboxetine—Nausea—Lovastatin—atherosclerosis	0.00042	0.00186	CcSEcCtD
Reboxetine—Rash—Simvastatin—atherosclerosis	0.000417	0.00184	CcSEcCtD
Reboxetine—Dermatitis—Simvastatin—atherosclerosis	0.000417	0.00184	CcSEcCtD
Reboxetine—Diarrhoea—Niacin—atherosclerosis	0.000416	0.00184	CcSEcCtD
Reboxetine—Headache—Simvastatin—atherosclerosis	0.000415	0.00183	CcSEcCtD
Reboxetine—Nausea—Ezetimibe—atherosclerosis	0.000412	0.00182	CcSEcCtD
Reboxetine—Diarrhoea—Pravastatin—atherosclerosis	0.000409	0.00181	CcSEcCtD
Reboxetine—Dizziness—Niacin—atherosclerosis	0.000402	0.00177	CcSEcCtD
Reboxetine—Phenprocoumon—ALB—atherosclerosis	0.000398	0.0513	CrCbGaD
Reboxetine—Dizziness—Pravastatin—atherosclerosis	0.000396	0.00175	CcSEcCtD
Reboxetine—Nausea—Simvastatin—atherosclerosis	0.000393	0.00174	CcSEcCtD
Reboxetine—Vomiting—Niacin—atherosclerosis	0.000386	0.00171	CcSEcCtD
Reboxetine—Rash—Niacin—atherosclerosis	0.000383	0.00169	CcSEcCtD
Reboxetine—Dermatitis—Niacin—atherosclerosis	0.000383	0.00169	CcSEcCtD
Reboxetine—Headache—Niacin—atherosclerosis	0.000381	0.00168	CcSEcCtD
Reboxetine—Vomiting—Pravastatin—atherosclerosis	0.00038	0.00168	CcSEcCtD
Reboxetine—Rash—Pravastatin—atherosclerosis	0.000377	0.00167	CcSEcCtD
Reboxetine—Dermatitis—Pravastatin—atherosclerosis	0.000377	0.00166	CcSEcCtD
Reboxetine—Headache—Pravastatin—atherosclerosis	0.000375	0.00165	CcSEcCtD
Reboxetine—Nausea—Niacin—atherosclerosis	0.000361	0.00159	CcSEcCtD
Reboxetine—Nausea—Pravastatin—atherosclerosis	0.000355	0.00157	CcSEcCtD
Reboxetine—HTR2C—GPCR ligand binding—F2—atherosclerosis	3.82e-05	0.000861	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	3.81e-05	0.000859	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—GHRL—atherosclerosis	3.81e-05	0.000858	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLTP—atherosclerosis	3.8e-05	0.000857	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOA4—atherosclerosis	3.68e-05	0.00083	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	3.67e-05	0.000827	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLTP—atherosclerosis	3.59e-05	0.000808	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	3.57e-05	0.000804	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCR2—atherosclerosis	3.55e-05	0.000799	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EDNRA—atherosclerosis	3.55e-05	0.000799	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	3.54e-05	0.000797	CbGpPWpGaD
Reboxetine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.52e-05	0.000792	CbGpPWpGaD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	3.48e-05	0.000784	CbGpPWpGaD
Reboxetine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.47e-05	0.000781	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GHRL—atherosclerosis	3.46e-05	0.000779	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CCL2—atherosclerosis	3.41e-05	0.000768	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL4—atherosclerosis	3.39e-05	0.000764	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—KNG1—atherosclerosis	3.34e-05	0.000753	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AGTR1—atherosclerosis	3.32e-05	0.000749	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LTA4H—atherosclerosis	3.3e-05	0.000743	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCG8—atherosclerosis	3.3e-05	0.000743	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	3.23e-05	0.000728	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOA2—atherosclerosis	3.17e-05	0.000714	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LTA4H—atherosclerosis	3.11e-05	0.0007	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCG8—atherosclerosis	3.11e-05	0.0007	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.05e-05	0.000687	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—KNG1—atherosclerosis	3.04e-05	0.000684	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—UTS2—atherosclerosis	3.02e-05	0.000681	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AGTR1—atherosclerosis	3.02e-05	0.00068	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	2.96e-05	0.000666	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CX3CR1—atherosclerosis	2.9e-05	0.000653	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASR—atherosclerosis	2.9e-05	0.000653	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.85e-05	0.000642	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CX3CL1—atherosclerosis	2.84e-05	0.000641	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—EDN1—atherosclerosis	2.82e-05	0.000635	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CCL5—atherosclerosis	2.8e-05	0.00063	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CNR2—atherosclerosis	2.7e-05	0.000607	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CXCL8—atherosclerosis	2.69e-05	0.000607	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MMP3—atherosclerosis	2.69e-05	0.000606	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	2.68e-05	0.000605	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PRKCG—atherosclerosis	2.66e-05	0.000599	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCG1—atherosclerosis	2.61e-05	0.000587	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.57e-05	0.000578	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EDN1—atherosclerosis	2.56e-05	0.000576	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCL5—atherosclerosis	2.54e-05	0.000572	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.52e-05	0.000569	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.49e-05	0.000562	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.46e-05	0.000553	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LCAT—atherosclerosis	2.45e-05	0.000552	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—FABP4—atherosclerosis	2.45e-05	0.000552	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.42e-05	0.000546	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PRKCG—atherosclerosis	2.41e-05	0.000544	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOA4—atherosclerosis	2.41e-05	0.000542	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VWF—atherosclerosis	2.4e-05	0.000541	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOC3—atherosclerosis	2.39e-05	0.000538	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LDLR—atherosclerosis	2.37e-05	0.000535	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.36e-05	0.000533	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.34e-05	0.000528	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AGT—atherosclerosis	2.34e-05	0.000527	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.33e-05	0.000525	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL3—atherosclerosis	2.32e-05	0.000522	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LCAT—atherosclerosis	2.31e-05	0.00052	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—FABP4—atherosclerosis	2.31e-05	0.00052	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOA4—atherosclerosis	2.27e-05	0.000511	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.24e-05	0.000504	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.23e-05	0.000502	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NCF1—atherosclerosis	2.22e-05	0.0005	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.2e-05	0.000497	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.19e-05	0.000492	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—F2—atherosclerosis	2.16e-05	0.000487	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.14e-05	0.000483	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.14e-05	0.000482	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AGT—atherosclerosis	2.12e-05	0.000478	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EDNRA—atherosclerosis	2.1e-05	0.000472	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCR2—atherosclerosis	2.1e-05	0.000472	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CYBA—atherosclerosis	2.09e-05	0.00047	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOA2—atherosclerosis	2.07e-05	0.000467	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.07e-05	0.000467	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.07e-05	0.000467	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALOX15—atherosclerosis	2.07e-05	0.000467	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CG—atherosclerosis	2.07e-05	0.000466	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.06e-05	0.000464	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCG5—atherosclerosis	2.05e-05	0.000461	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PARP1—atherosclerosis	2.04e-05	0.00046	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GHRL—atherosclerosis	2.04e-05	0.00046	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLAT—atherosclerosis	2.04e-05	0.00046	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.03e-05	0.000458	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.03e-05	0.000458	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2e-05	0.00045	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LPA—atherosclerosis	1.98e-05	0.000445	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—F2—atherosclerosis	1.96e-05	0.000442	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.95e-05	0.00044	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.95e-05	0.00044	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOA2—atherosclerosis	1.95e-05	0.00044	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.95e-05	0.00044	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.93e-05	0.000434	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—BGN—atherosclerosis	1.91e-05	0.000431	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOA5—atherosclerosis	1.89e-05	0.000427	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CG—atherosclerosis	1.88e-05	0.000423	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LPA—atherosclerosis	1.86e-05	0.000419	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.82e-05	0.000411	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.81e-05	0.000407	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—BGN—atherosclerosis	1.8e-05	0.000406	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KNG1—atherosclerosis	1.79e-05	0.000404	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.79e-05	0.000402	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AGTR1—atherosclerosis	1.78e-05	0.000402	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALOX5—atherosclerosis	1.76e-05	0.000397	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CCL2—atherosclerosis	1.75e-05	0.000394	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PLG—atherosclerosis	1.74e-05	0.000391	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.72e-05	0.000387	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.69e-05	0.000382	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.66e-05	0.000374	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SOCS3—atherosclerosis	1.65e-05	0.000371	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.61e-05	0.000362	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP3—atherosclerosis	1.59e-05	0.000358	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF2—atherosclerosis	1.58e-05	0.000356	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NAMPT—atherosclerosis	1.58e-05	0.000356	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LIPC—atherosclerosis	1.57e-05	0.000354	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOC3—atherosclerosis	1.56e-05	0.000351	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LDLR—atherosclerosis	1.55e-05	0.000349	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOB—atherosclerosis	1.54e-05	0.000346	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCL8—atherosclerosis	1.52e-05	0.000343	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CETP—atherosclerosis	1.51e-05	0.000341	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EDN1—atherosclerosis	1.51e-05	0.00034	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.51e-05	0.00034	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.51e-05	0.00034	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL5—atherosclerosis	1.5e-05	0.000338	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.49e-05	0.000335	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.49e-05	0.000335	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.48e-05	0.000334	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.48e-05	0.000333	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.47e-05	0.000331	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LPL—atherosclerosis	1.47e-05	0.00033	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.46e-05	0.000329	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.46e-05	0.000328	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SCARB1—atherosclerosis	1.45e-05	0.000327	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CETP—atherosclerosis	1.43e-05	0.000321	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	1.43e-05	0.000321	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SPP1—atherosclerosis	1.39e-05	0.000313	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	1.38e-05	0.000311	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMGCR—atherosclerosis	1.37e-05	0.000309	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.37e-05	0.000308	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.35e-05	0.000303	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.34e-05	0.000302	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.29e-05	0.000291	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	1.29e-05	0.000289	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.28e-05	0.000287	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.28e-05	0.000287	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.28e-05	0.000287	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.28e-05	0.000287	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.26e-05	0.000284	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AGT—atherosclerosis	1.25e-05	0.000283	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LEP—atherosclerosis	1.23e-05	0.000277	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOE—atherosclerosis	1.23e-05	0.000277	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ABCA1—atherosclerosis	1.22e-05	0.000275	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CAV1—atherosclerosis	1.22e-05	0.000274	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LPA—atherosclerosis	1.22e-05	0.000274	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APOA1—atherosclerosis	1.22e-05	0.000274	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—BGN—atherosclerosis	1.18e-05	0.000266	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ESR1—atherosclerosis	1.17e-05	0.000264	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.17e-05	0.000263	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—F2—atherosclerosis	1.16e-05	0.000261	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.15e-05	0.000259	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.12e-05	0.000253	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	1.11e-05	0.00025	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.09e-05	0.000244	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	1.06e-05	0.000239	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—INS—atherosclerosis	1.05e-05	0.000237	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HMOX1—atherosclerosis	1.05e-05	0.000236	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCL2—atherosclerosis	1.03e-05	0.000233	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1—atherosclerosis	1.02e-05	0.000229	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOB—atherosclerosis	1e-05	0.000226	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HMOX1—atherosclerosis	9.87e-06	0.000222	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GSTM1—atherosclerosis	9.76e-06	0.00022	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.73e-06	0.000219	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LIPC—atherosclerosis	9.67e-06	0.000218	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	9.64e-06	0.000217	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOC3—atherosclerosis	9.61e-06	0.000217	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LPL—atherosclerosis	9.58e-06	0.000216	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LDLR—atherosclerosis	9.55e-06	0.000215	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOB—atherosclerosis	9.45e-06	0.000213	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GPX1—atherosclerosis	9.35e-06	0.000211	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CETP—atherosclerosis	9.33e-06	0.00021	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOS3—atherosclerosis	9.21e-06	0.000207	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.2e-06	0.000207	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CD36—atherosclerosis	9.1e-06	0.000205	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LPL—atherosclerosis	9.03e-06	0.000203	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.94e-06	0.000201	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GPX1—atherosclerosis	8.81e-06	0.000198	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—atherosclerosis	8.63e-06	0.000194	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CD36—atherosclerosis	8.58e-06	0.000193	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARA—atherosclerosis	8.46e-06	0.000191	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.44e-06	0.00019	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AGT—atherosclerosis	8.2e-06	0.000185	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	8.17e-06	0.000184	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.13e-06	0.000183	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOE—atherosclerosis	8.03e-06	0.000181	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARA—atherosclerosis	7.97e-06	0.00018	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CAV1—atherosclerosis	7.96e-06	0.000179	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—APOA1—atherosclerosis	7.94e-06	0.000179	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	7.89e-06	0.000178	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	7.77e-06	0.000175	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AGT—atherosclerosis	7.72e-06	0.000174	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOE—atherosclerosis	7.57e-06	0.00017	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.52e-06	0.000169	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CAV1—atherosclerosis	7.5e-06	0.000169	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—APOA1—atherosclerosis	7.48e-06	0.000169	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	7.39e-06	0.000166	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	7.31e-06	0.000165	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CG—atherosclerosis	7.25e-06	0.000163	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	7.18e-06	0.000162	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	7.17e-06	0.000161	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARG—atherosclerosis	6.99e-06	0.000158	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—INS—atherosclerosis	6.86e-06	0.000155	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	6.83e-06	0.000154	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	6.63e-06	0.000149	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARG—atherosclerosis	6.59e-06	0.000148	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	6.57e-06	0.000148	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—INS—atherosclerosis	6.46e-06	0.000146	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.45e-06	0.000145	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—atherosclerosis	6.29e-06	0.000142	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	6.28e-06	0.000141	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOB—atherosclerosis	6.18e-06	0.000139	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	6.09e-06	0.000137	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—NOS3—atherosclerosis	6.02e-06	0.000136	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.01e-06	0.000135	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—atherosclerosis	5.93e-06	0.000134	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LPL—atherosclerosis	5.9e-06	0.000133	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPX1—atherosclerosis	5.76e-06	0.00013	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—NOS3—atherosclerosis	5.67e-06	0.000128	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CD36—atherosclerosis	5.61e-06	0.000126	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—atherosclerosis	5.5e-06	0.000124	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.31e-06	0.00012	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARA—atherosclerosis	5.21e-06	0.000117	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.18e-06	0.000117	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AGT—atherosclerosis	5.05e-06	0.000114	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOE—atherosclerosis	4.95e-06	0.000111	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CAV1—atherosclerosis	4.9e-06	0.00011	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—APOA1—atherosclerosis	4.89e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—atherosclerosis	4.59e-06	0.000103	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.46e-06	0.000101	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARG—atherosclerosis	4.31e-06	9.71e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	4.23e-06	9.53e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—INS—atherosclerosis	4.23e-06	9.52e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—atherosclerosis	3.87e-06	8.73e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—NOS3—atherosclerosis	3.71e-06	8.35e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.39e-06	7.64e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—atherosclerosis	2.77e-06	6.23e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.61e-06	5.87e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.7e-06	3.84e-05	CbGpPWpGaD
